CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β-Reference-Cited by-同舟云学术

CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β

Published:2016-01-18 Issue:1 Volume:20 Page:116-125
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Kindlund Bert,Sjöling Åsa,Yakkala Chakradhar,Adamsson Jenni,Janzon Anders,Hansson Lars-Erik,Hermansson Michael,Janson Peter,Winqvist Ola,Lundin Samuel B.^ORCID

Funder

Vetenskapsrådet (SE)

Cancerfonden (SE)

Stiftelsen Assar Gabrielssons Fond (SE)

ALF-Göteborg (SE)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-015-0591-z.pdf

Reference54 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108

2. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009;472:467–77.

3. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol. 2006;1:63–96.

4. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, Poire ED, Sgouras D, et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012;122:1553–66.

5. Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, et al. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe. 2012;12:764–77.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact the impact of gut microbiota on gastric cancer via immune cells: a comprehensive Mendelian randomization study and mediation analysis;Discover Oncology;2024-08-31

2. New Approaches in Gastric Cancer Immunotherapy;Gastric Cancer - Progress and Challenges in the Era of Precision Medicine [Working Title];2024-07-01

3. Investigating the impact of gut microbiota on gastric cancer through the involvement of immune cells: a comprehensive Mendelian randomization study and mediation analysis;2024-05-24

4. Combined scRNA-Seq and bulk RNA-Seq analysis suggests that ITGB2 has potential as a prognostic factor for the immune microenvironment of gastric cancer tumours and as an indicator of tumour microenvironment remodelling.;2024-05-23

5. Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy;International Immunopharmacology;2024-05